Stephen I. Foundling
- Molecular Biology
- Infectious Diseases top 10%
- Oncology
- Epidemiology
- Biotechnology top 10%
- Co-authors
- Michel MonodBen M. DunnMartin FusekKenneth W. JacksonXinli LinJordan TangGerald KoelschJeffrey A. Loy
- Topics
- Peptidase Inhibition and Analysis (6 papers)Antifungal resistance and susceptibility (4 papers)Enzyme Structure and Function (4 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Stephen I. Foundling
15 papers receiving 459 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 251
- Infectious Diseases 196
- Oncology 131
- Epidemiology 95
- Biotechnology 68
Countries citing papers authored by Stephen I. Foundling
This map shows the geographic impact of Stephen I. Foundling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen I. Foundling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen I. Foundling more than expected).
Fields of papers citing papers by Stephen I. Foundling
This network shows the impact of papers produced by Stephen I. Foundling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen I. Foundling. The network helps show where Stephen I. Foundling may publish in the future.
Co-authorship network of co-authors of Stephen I. Foundling
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen I. Foundling. A scholar is included among the top collaborators of Stephen I. Foundling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen I. Foundling. Stephen I. Foundling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 76 | |
| 2 | 16 | |
| 3 | 3 | |
| 4 | 13 | |
| 5 | 28 | |
| 6 | 17 | |
| 7 | 42 | |
| 8 | 60 | |
| 9 | 1 | |
| 10 | 41 | |
| 11 | 24 | |
| 12 | 60 | |
| 13 | 14 | |
| 14 | 57 | |
| 15 | 13 |
About Stephen I. Foundling
Stephen I. Foundling is a scholar working on Biotechnology, Infectious Diseases and Oncology, having authored 15 papers that have together received 465 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Antifungal resistance and susceptibility (4 papers) and Enzyme Structure and Function (4 papers). The work is most often cited by research in Infectious Diseases (196 citations), Biotechnology (68 citations) and Virology (36 citations). Stephen I. Foundling has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Michel Monod, Ben M. Dunn, Martin Fusek, Kenneth W. Jackson, Xinli Lin, Jordan Tang, Gerald Koelsch, Jeffrey A. Loy, Martin J. Valler and John Kay. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.